William H. Stuart

2.0k total citations · 1 hit paper
19 papers, 1.3k citations indexed

About

William H. Stuart is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, William H. Stuart has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 7 papers in Neurology and 7 papers in Oncology. Recurrent topics in William H. Stuart's work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (6 papers). William H. Stuart is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (6 papers). William H. Stuart collaborates with scholars based in United States, Switzerland and France. William H. Stuart's co-authors include Frances Lynn, Steven Galetta, Bianca Weinstock‐Guttman, Peter A. Calabresi, Fred Lublin, Ernst-Wilhelm Radüe, Michael Panzara, Richard A. Rudick, Daniel Wynn and Christian Confavreux and has published in prestigious journals such as New England Journal of Medicine, JAMA and Neurology.

In The Last Decade

William H. Stuart

18 papers receiving 1.2k citations

Hit Papers

Natalizumab plus Interferon Beta-1a for Relapsing Multipl... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. Stuart United States 12 986 529 343 282 213 19 1.3k
W. H. Stuart United States 7 1.1k 1.2× 411 0.8× 439 1.3× 257 0.9× 333 1.6× 8 1.5k
B. C. Kieseier Germany 15 597 0.6× 285 0.5× 271 0.8× 233 0.8× 167 0.8× 62 1.2k
Kathleen Hawker United States 18 1.2k 1.2× 310 0.6× 621 1.8× 389 1.4× 324 1.5× 29 1.6k
Alexandros Tselis United States 21 729 0.7× 319 0.6× 472 1.4× 151 0.5× 242 1.1× 40 1.3k
Harold Koendgen Switzerland 15 1.1k 1.2× 445 0.8× 487 1.4× 261 0.9× 269 1.3× 38 1.4k
Paul O’Connor Canada 11 926 0.9× 284 0.5× 329 1.0× 220 0.8× 294 1.4× 22 1.1k
Christina Caon United States 20 783 0.8× 220 0.4× 381 1.1× 117 0.4× 211 1.0× 36 1.0k
Becky Parks United States 17 680 0.7× 201 0.4× 348 1.0× 319 1.1× 167 0.8× 31 1.2k
Norman J. Kachuck United States 9 707 0.7× 147 0.3× 343 1.0× 234 0.8× 220 1.0× 14 898
R. Philip Kinkel United States 11 529 0.5× 355 0.7× 257 0.7× 155 0.5× 168 0.8× 15 850

Countries citing papers authored by William H. Stuart

Since Specialization
Citations

This map shows the geographic impact of William H. Stuart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Stuart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Stuart more than expected).

Fields of papers citing papers by William H. Stuart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Stuart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Stuart. The network helps show where William H. Stuart may publish in the future.

Co-authorship network of co-authors of William H. Stuart

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Stuart. A scholar is included among the top collaborators of William H. Stuart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Stuart. William H. Stuart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cree, Bruce, et al.. (2011). Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis. Archives of Neurology. 68(4). 464–464. 32 indexed citations
2.
Weinstock‐Guttman, Bianca, Steven Galetta, Eva Havrdová, et al.. (2011). Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. Journal of Neurology. 259(5). 898–905. 53 indexed citations
3.
Radüe, Ernst-Wilhelm, William H. Stuart, Peter A. Calabresi, et al.. (2010). Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. Journal of the Neurological Sciences. 292(1-2). 28–35. 43 indexed citations
4.
Hutchinson, Michael, Ludwig Kappos, Peter A. Calabresi, et al.. (2009). The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. Journal of Neurology. 256(6). 1035–1037. 9 indexed citations
5.
Stuart, William H.. (2007). Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Current Medical Research and Opinion. 23(6). 1199–1208. 4 indexed citations
6.
Rudick, Richard A., William H. Stuart, Peter A. Calabresi, et al.. (2006). Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis. New England Journal of Medicine. 354(9). 911–923. 982 indexed citations breakdown →
7.
Stuart, William H. & Patrick Vermersch. (2004). Concomitant therapy for multiple sclerosis. Neurology. 63(11_suppl_5). S28–34. 4 indexed citations
8.
Stuart, William H.. (2004). Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.. PubMed. 10(3 Suppl B). S19–25. 16 indexed citations
9.
Stuart, William H., Stanley Cohan, John R. Richert, & Anat Achiron. (2004). Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis. Neurology. 63(11_suppl_5). S19–27. 13 indexed citations
10.
Bar‐Or, Amit, et al.. (2000). A novel population of B7-1+ T cells producing intracellular IL-4 is decreased in patients with multiple sclerosis. European Journal of Immunology. 30(7). 2092–2100. 12 indexed citations
11.
Stuart, William H., et al.. (2000). Registry of Multiple Sclerosis Treatment and Care (MSTRAC) Patient and Physician Characteristics. International Journal of MS Care. 2(4). 25–36. 3 indexed citations
12.
Munschauer, Frederick & William H. Stuart. (1997). Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis. Clinical Therapeutics. 19(5). 868–882. 18 indexed citations
13.
Munsat, Theodore L., William H. Stuart, & Ronald E. Cranford. (1989). Guidelines on the vegetative state. Neurology. 39(1). 123–123. 14 indexed citations
14.
Stuart, William H., et al.. (1983). In Praise of Fewer Administrators..
15.
Stuart, William H.. (1982). Geriatrie Neurology for the Otolaryngologist. Otolaryngologic Clinics of North America. 15(2). 329–351. 3 indexed citations
16.
Stuart, William H.. (1982). Geriatric neurology for the otolaryngologist.. PubMed. 15(2). 329–51. 4 indexed citations
17.
Hoffman, Paul M., William H. Stuart, Kenneth M. Earle, & Jacob A. Brody. (1971). Hereditary late‐onset cerebellar degeneration. Neurology. 21(8). 771–771. 21 indexed citations
18.
Stuart, William H.. (1969). Evaluation of Monovalent Influenza Vaccine in a Retirement Community During the Epidemic of 1965-1966. JAMA. 209(2). 232–232. 36 indexed citations
19.
Grodins, Fred S., et al.. (1960). Performance characteristics of the right heart bypass preparation. American Journal of Physiology-Legacy Content. 198(3). 552–560. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026